ASCRS 2020: Assessing effectiveness of intracameral phenylephrine/ketorolac post-cataract surgery

May 16, 2020
Alex Delaney-Gesing

Denise Visco, MD, speaks with Ophthalmology Times Executive Editor David Hutton on the findings from her poster on the effects of intracameral phenylephrine/ketorolac 1.0%/0.3% on postoperative cystoid macular edema, iritis, pain, and photophobia following cataract surgery, during the 2020 ASCRS virtual meeting.

 

See more ASCRS coverage content here

Related Content:

ASCRS | News | Cataract Surgery